SACURISE 50

About

Sacurise 50 is an innovative combination medication, presumed to contain sacubitril and valsartan, specifically indicated for the treatment of chronic heart failure with reduced ejection fraction. Sacubitril functions as a neprilysin inhibitor, augmenting the beneficial natriuretic peptide system which promotes vasodilation and diuresis. Concurrently, valsartan, an angiotensin receptor blocker (ARB), counteracts the detrimental effects of the renin-angiotensin-aldosterone system, such as vasoconstriction and fluid retention. This dual, complementary mechanism of action works synergistically to significantly reduce cardiovascular mortality and decrease the frequency of heart failure hospitalizations. By improving cardiac function, reducing ventricular remodeling, and managing fluid overload, Sacurise 50 offers a substantial advancement in the management of this debilitating condition, enhancing patient prognosis and quality of life.

Uses

• Treatment of chronic heart failure with reduced ejection fraction.
• Reduces the risk of cardiovascular death.
• Decreases heart failure hospitalizations.
• Improves symptoms and physical limitations associated with heart failure.

Directions For Use

Take one tablet orally twice daily, with or without food, as prescribed by your cardiologist. Do not discontinue without medical advice.

Benefits

• Significantly reduces cardiovascular mortality.
• Lowers rates of heart failure hospitalizations.
• Improves cardiac function and symptoms.
• Offers a novel mechanism for heart failure management.
• Better outcomes compared to ACE inhibitors alone in some patients.
• Enhances quality of life for heart failure patients.

Side Effects

• Hypotension (low blood pressure)
• Hyperkalemia (high potassium levels)
• Cough
• Dizziness
• Renal impairment
• Fatigue
• Nausea
• Diarrhea
• Headache
• Angioedema (rare but serious)
• Anemia
• Syncope

Safety Measures

• Alcohol - Avoid or limit alcohol, as it can exacerbate hypotension and dizziness, especially when initiating treatment.
• Pregnancy - Contraindicated during pregnancy due to potential fetal harm; use effective contraception.
• Breastfeeding - Not recommended during breastfeeding; consult your doctor for alternatives.
• Liver - Use with caution in patients with moderate liver impairment; contraindicated in severe liver disease.
• Kidney - Requires careful monitoring of renal function; dose adjustment may be necessary in severe impairment.
• Lung - Generally safe for use in patients with lung conditions; no specific contraindications.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.